Mediterranean diet reduces risk of CVD, death among women
The popular diet appears to benefit women even more than it benefits men.
Related Articles
Cardiologists share update after world’s first implant of new optimizer device for tricuspid regurgitation
The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.
Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.
FDA clears new catheter for peripheral blood clots
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.
Q&A: Cleveland Clinic’s Lars Svensson previews AATS annual meeting
Svensson, a prominent voice in cardiothoracic surgery, said he has seen a rise in enthusiasm ahead of this year’s meeting.
Cardiologists, thoracic surgeons applaud FTC’s ban of most noncompete clauses
The Society for Cardiovascular Angiography & Interventions and Society of Thoracic Surgeons have both shared statements in support of the ban, which is already being…
American Heart Association thinks pharmacists can play a bigger role in AFib care
Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for…
TAVR, SAVR linked to similar QOL improvements for intermediate-risk patients after five years
TAVR was initially associated with greater benefits than surgery, but that difference faded by the end of the first year.
‘Your heart belongs here’: Improved device, economics help cardiologists keep more patients close to home
Munster, Indiana, is a thriving suburb 30 miles south of the heart of Chicago. It’s a place where the locals like to stay local, especially…
Diabetic cardiomyopathy treatment shows promise in ARISE-HF
James Januzzi Jr., MD, said the treatment’s overall impact was neutral, but he and his team saw “a very clear and encouraging signal.”
AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required
Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.